Literature DB >> 20692689

The diagnosis and management of anaphylaxis practice parameter: 2010 update.

Phillip Lieberman1, Richard A Nicklas, John Oppenheimer, Stephen F Kemp, David M Lang, David I Bernstein, Jonathan A Bernstein, A Wesley Burks, Anna M Feldweg, Jordan N Fink, Paul A Greenberger, David B K Golden, John M James, Stephen F Kemp, Dennis K Ledford, Phillip Lieberman1, Albert L Sheffer, David I Bernstein, Joann Blessing-Moore, Linda Cox, David A Khan, David Lang, Richard A Nicklas, John Oppenheimer, Jay M Portnoy, Christopher Randolph, Diane E Schuller, Sheldon L Spector, Stephen Tilles, Dana Wallace.   

Abstract

These parameters were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council of Allergy, Asthma and Immunology. The AAAAI and the ACAAI have jointly accepted responsibility for establishing "The Diagnosis and Management of Anaphylaxis Practice Parameter: 2010 Update." This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, or the Joint Council of Allergy, Asthma and Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion. Copyright (c) 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20692689     DOI: 10.1016/j.jaci.2010.06.022

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  127 in total

1.  Food-induced anaphylaxis.

Authors:  Antonella Cianferoni; Antonella Muraro
Journal:  Immunol Allergy Clin North Am       Date:  2011-11-21       Impact factor: 3.479

Review 2.  Clinical pharmacology, uses, and adverse reactions of iodinated contrast agents: a primer for the non-radiologist.

Authors:  Jeffrey J Pasternak; Eric E Williamson
Journal:  Mayo Clin Proc       Date:  2012-04       Impact factor: 7.616

Review 3.  The Epidemiology of Anaphylaxis.

Authors:  Joyce E Yu; Robert Y Lin
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

Review 4.  Pathogenesis, newly recognized etiologies, and management of idiopathic anaphylaxis.

Authors:  James L Kuhlen; Yamini V Virkud
Journal:  Discov Med       Date:  2015-02       Impact factor: 2.970

Review 5.  Kounis syndrome (allergic acute coronary syndrome): different views in allergologic and cardiologic literature.

Authors:  Filippo Fassio; Fabio Almerigogna
Journal:  Intern Emerg Med       Date:  2012-01-22       Impact factor: 3.397

6.  Life-threatening anaphylactic shock due to chlorhexidine on the central venous catheter: a case series.

Authors:  Meilin Weng; Minmin Zhu; Wankun Chen; Changhong Miao
Journal:  Int J Clin Exp Med       Date:  2014-12-15

7.  Case fatality and population mortality associated with anaphylaxis in the United States.

Authors:  Larry Ma; Theodore M Danoff; Larry Borish
Journal:  J Allergy Clin Immunol       Date:  2013-12-14       Impact factor: 10.793

8.  Immediate and delayed-onset systemic reactions after subcutaneous immunotherapy injections: ACAAI/AAAAI surveillance study of subcutaneous immunotherapy: year 2.

Authors:  Tolly G Epstein; Gary M Liss; Karen Murphy-Berendts; David I Bernstein
Journal:  Ann Allergy Asthma Immunol       Date:  2011-06-17       Impact factor: 6.347

9.  A multifaceted intervention for patients with anaphylaxis increases epinephrine use in adult emergency department.

Authors:  Veena Manivannan; Erik P Hess; Venkatesh R Bellamkonda; David M Nestler; M Fernanda Bellolio; John B Hagan; Kharmene L Sunga; Wyatt W Decker; James T C Li; Lori N Scanlan-Hanson; Samuel C Vukov; Ronna L Campbell
Journal:  J Allergy Clin Immunol Pract       Date:  2014-02-16

Review 10.  Mastocytosis: update on pharmacotherapy and future directions.

Authors:  Juan Carlos Cardet; Cem Akin; Min Jung Lee
Journal:  Expert Opin Pharmacother       Date:  2013-10       Impact factor: 3.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.